Positron emission tomography measures of endogenous opioid neurotransmission and impulsiveness traits in humans
- PMID: 19805703
- PMCID: PMC3085183
- DOI: 10.1001/archgenpsychiatry.2009.134
Positron emission tomography measures of endogenous opioid neurotransmission and impulsiveness traits in humans
Abstract
Context: The endogenous opioid system and opioid mu receptors (mu-receptors) are known to interface environmental events, positive (eg, relevant emotional stimuli) and negative (eg, stressors), with pertinent behavioral responses and to regulate motivated behavior.
Objective: To examine the degree to which trait impulsiveness (the tendency to act on cravings and urges rather than to delay gratification) is predicted by baseline mu-receptor availability or the response of this system to a standardized, experientially matched stressor.
Design, setting, and patients: Nineteen young healthy male volunteers completed a personality questionnaire (NEO Personality Inventory, Revised) and underwent positron emission tomography scans with the mu-receptor-selective radiotracer carfentanil labeled with carbon 11. Measures of receptor concentrations were obtained at rest and during receipt of an experimentally maintained pain stressor of matched intensity between subjects.
Main outcome measures: Baseline receptor levels and stress-induced activation of mu-opioid system neurotransmission compared between subjects scoring above and below the population median on the NEO Personality Inventory, Revised, impulsiveness subscale and the orthogonal dimension (deliberation) expected to interact with it.
Results: High impulsiveness and low deliberation scores were associated with significantly higher regional mu-receptor concentrations and greater stress-induced endogenous opioid system activation. Effects were obtained in the prefrontal and orbitofrontal cortices, anterior cingulate, thalamus, nucleus accumbens, and basolateral amygdala-all regions involved in motivated behavior and the effects of drugs of abuse. Availability of the mu-receptor and the magnitude of stress-induced endogenous opioid activation in these regions accounted for 17% to 49% of the variance in these personality traits.
Conclusions: Individual differences in the function of the endogenous mu-receptor system predict personality traits that confer vulnerability to or resiliency against risky behaviors such as the predisposition to develop substance use disorders. These personality traits are also implicated in psychopathological states (eg, personality disorders) in which variations in the function of this neurotransmitter system also may play a role.
Figures
Similar articles
-
Dysregulation of regional endogenous opioid function in borderline personality disorder.Am J Psychiatry. 2010 Aug;167(8):925-33. doi: 10.1176/appi.ajp.2010.09091348. Epub 2010 May 3. Am J Psychiatry. 2010. PMID: 20439388 Free PMC article.
-
Dysregulation of endogenous opioid emotion regulation circuitry in major depression in women.Arch Gen Psychiatry. 2006 Nov;63(11):1199-208. doi: 10.1001/archpsyc.63.11.1199. Arch Gen Psychiatry. 2006. PMID: 17088500 Clinical Trial.
-
Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses.Arch Gen Psychiatry. 2008 Feb;65(2):220-31. doi: 10.1001/archgenpsychiatry.2007.34. Arch Gen Psychiatry. 2008. PMID: 18250260 Clinical Trial.
-
Expectancy Modulation of Opioid Neurotransmission.Int Rev Neurobiol. 2018;138:17-37. doi: 10.1016/bs.irn.2018.02.003. Epub 2018 Apr 2. Int Rev Neurobiol. 2018. PMID: 29681324 Free PMC article. Review.
-
Interface of physical and emotional stress regulation through the endogenous opioid system and mu-opioid receptors.Prog Neuropsychopharmacol Biol Psychiatry. 2005 Dec;29(8):1264-80. doi: 10.1016/j.pnpbp.2005.08.011. Epub 2005 Oct 26. Prog Neuropsychopharmacol Biol Psychiatry. 2005. PMID: 16256255 Review.
Cited by
-
Cerebral μ-opioid and CB1 receptor systems have distinct roles in human feeding behavior.Transl Psychiatry. 2021 Aug 27;11(1):442. doi: 10.1038/s41398-021-01559-5. Transl Psychiatry. 2021. PMID: 34453034 Free PMC article.
-
Dissociable effects of kappa-opioid receptor activation on impulsive phenotypes in wistar rats.Neuropsychopharmacology. 2013 Oct;38(11):2278-85. doi: 10.1038/npp.2013.129. Epub 2013 May 21. Neuropsychopharmacology. 2013. PMID: 23689673 Free PMC article.
-
Molecular Imaging of Opioid and Dopamine Systems: Insights Into the Pharmacogenetics of Opioid Use Disorders.Front Psychiatry. 2019 Sep 18;10:626. doi: 10.3389/fpsyt.2019.00626. eCollection 2019. Front Psychiatry. 2019. PMID: 31620026 Free PMC article. Review.
-
The role of the opioid system in decision making and cognitive control: A review.Cogn Affect Behav Neurosci. 2019 Jun;19(3):435-458. doi: 10.3758/s13415-019-00710-6. Cogn Affect Behav Neurosci. 2019. PMID: 30963411 Free PMC article. Review.
-
Opioid system and human emotions.Br J Pharmacol. 2018 Jul;175(14):2737-2749. doi: 10.1111/bph.13812. Epub 2017 May 24. Br J Pharmacol. 2018. PMID: 28394427 Free PMC article. Review.
References
-
- Whiteside SP, Lynam DR. The Five Factor Model and impulsivity: using a structural model of personality to understand impulsivity. Personality and Individual Differences. 2001 Dec 21;30:669–689.
-
- Smith GT, Fischer S, Cyders MA, Annus AM, Spillane NS, McCarthy DM. On the validity and utility of discriminating among impulsivity-like traits. Assessment. 2007 Jun 1;14(2):155–170. - PubMed
-
- Fischer S, Anderson KG, Smith GT. Coping with distress by eating or drinking: role of trait urgency and expectancies. Psychology of addictive behaviors: journal of the Society of Psychologists in Addictive Behaviors. 2004 Sep 1;18(3):269–274. - PubMed
-
- Madden GJ, Petry NM, Badger GJ, Bickel WK. Impulsive and self-control choices in opioid-dependent patients and non-drug-using control participants: drug and monetary rewards. Experimental and clinical psychopharmacology. 1997 Aug 1;5(3):256–262. - PubMed
-
- Clark L, Robbins TW, Ersche KD, Sahakian BJ. Reflection impulsivity in current and former substance users. Biological psychiatry. 2006 Sep 1;60(5):515–522. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials